Abstract:Elevated levels of MMP‐1, MMP‐2, MMP‐3, OPN, and TSLP were detected at sites affected by periodontitis and peri‐implantitis compared to sites with healthy teeth and implants. The cytokine OPN may serve as a biomarker for periodontitis, whereas the proteolytic enzyme MMP‐2 and the cytokine TSLP might be potential biomarkers for both periodontitis and peri‐implantitis. Aim Periodontitis and peri‐implantitis are chronic inflammatory diseases characterized by the destruction of supporting tissues. Despite some similarities, it is essential to understand the differences in how these diseases elicit unique host responses within the oral tissues, including the production of selected matrix metalloproteinases (MMPs) and inflammatory mediators involved in tissue remodelling. The aim of this study was to evaluate the levels of proteolytic enzymes MMP‐1, MMP‐2, MMP‐3, as well as the inflammatory mediators osteopontin (OPN), pentraxin‐3 (PTX3), and thymic stromal lymphopoietin (TSLP) in crevicular fluid samples collected from healthy, periodontitis‐affected, and peri‐implantitis sites. Methods Gingival crevicular fluid (GCF) and peri‐implant crevicular fluid (PICF) samples were collected from healthy and diseased teeth and implant sites of 163 patients. The MMP‐1, MMP‐2, MMP‐3, OPN, PTX3, and TSLP levels were determined using commercially available immunoassays. A linear mixed model procedure was adopted for multilevel analyses, using biomarker levels as the outcome variable to compare two types of sites. The diagnostic accuracy of the biomarkers was evaluated by Youden's index to estimate the sensitivity, specificity and the area under curve (AUC). Results The levels of MMP‐1, MMP‐2, MMP‐3, OPN, and TSLP were higher at sites with periodontitis and peri‐implantitis compared to the levels at sites with healthy teeth and healthy implants. No significant differences were observed in the levels of the measured markers between the sites diagnosed with periodontitis and those diagnosed with peri‐implantitis. The highest diagnostic potential at implant sites was found for MMP‐2 (AUC = 0.74) and TSLP (AUC = 0.72). The highest AUC (0.82) at tooth sites was found for OPN. Conclusions The findings indicate that the proteolytic enzyme MMP‐2 and the cytokine TSLP might be potential biomarkers for both periodontitis and peri‐implantitis, whereas the proinflammatory cytokine OPN may serve as a biomarker for periodontitis. Further studies are required to confirm the utility of these biomarkers and explore their potential clinical applications.

MMP-12 and S100s in saliva reflect different aspects of periodontal inflammation

Salivary IL-1β, IL-6, and IL-10 Are Key Biomarkers of Periodontitis Severity

Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA-compliant systematic review and meta-analysis.

Levels of matrix metalloproteinases in saliva during orthodontic tooth movement

Levels of matrix metalloproteinase‐1 (MMP‐1), MMP‐2, MMP‐3, osteopontin, pentraxin‐3, and thymic stromal lymphopoietin in crevicular fluid samples from peri‐implantitis, periodontitis, and healthy sites

[Detection and Significance of IL-1beta and MMP-8 in Patients with Periodontitis of Whole Unstimulated Saliva].

Investigating the role of salivary Interleukin‐40 levels in diagnosing periodontal diseases

Expression of selected inflammatory proteins and metalloproteinases in periodontitis

Common complement factor H polymorphisms are linked with periodontitis in elderly patients

S100A2 level changes are related to human periodontitis

aMMP-8 POCT vs. Other Potential Biomarkers in Chair-Side Diagnostics and Treatment Monitoring of Severe Periodontitis

Association between metabolic syndrome and salivary MMP‐8, myeloperoxidase in periodontitis

Salivary advanced glycated end products, their receptors, and aMMP‐8 in periodontitis patients with varying glycemic levels: A cross‐sectional study

Evaluation of Salivary Biomarkers for the Diagnosis of Periodontitis

Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma

A Study Into Systemic and Oral Levels of Proinflammatory Biomarkers Associated With Endpoints After Active Non‐Surgical Periodontal Therapy

Gingival crevicular fluid matrix metalloproteinase-25 and -26 levels in periodontal disease

Effects of Saliva From Periodontally Healthy and Diseased Subjects on Barrier Function and the Inflammatory Response in in vitro Models of the Oral Epithelium

Discovery, validation, and diagnostic ability of multiple protein-based biomarkers in saliva and gingival crevicular fluid to distinguish between health and periodontal diseases

Salivary S100 proteins screen periodontitis among Korean adults